Details:

Journal Article:
MMWR. Morbidity and Mortality Weekly Report
Personal Author:
Simeone, Regina M. ; Shapiro-Mendoza, Carrie K. ; Meaney-Delman, Dana ; Petersen, Emily E. ; Galang, Romeo R. ; ... More +
Simeone, Regina M. ; Shapiro-Mendoza, Carrie K. ; Meaney-Delman, Dana ; Petersen, Emily E. ; Galang, Romeo R. ; Oduyebo, Titilope ; Rivera-García, Brenda ; Newsome, Kimberly B. ; Perez-Padilla, Janice ; Williams, Tonya R. ; Biggerstaff, Matthew ; Jamieson, Denise J. ; Honein, Margaret A. Less -
Corporate Authors:
Centers for Disease Control and Prevention (U.S.)Zika and Pregnancy Working Group.
Description:
On May 20, 2016, this report was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).

Zika Virus is a cause of microcephaly and brain abnormalities (1), and it is the first known mosquito-borne infection to cause Congenital anomalies in humans. The establishment of a comprehensive Surveillance system to monitor pregnant women with Zika Virus infection will provide data to further elucidate the full range of potential outcomes for fetuses and infants of mothers with asymptomatic and symptomatic Zika Virus infection during pregnancy. In February 2016, Zika Virus disease and Congenital Zika Virus infections became nationally notifiable conditions in the United States (2). Cases in pregnant women with laboratory evidence of Zika Virus infection who have either 1) symptomatic infection or 2) asymptomatic infection with diagnosed Complications of pregnancy can be reported as cases of Zika Virus disease to ArboNET* (2), CDC’s national arboviral Diseases Surveillance system. Under existing interim guidelines from the Council for State and Territorial Epidemiologists (CSTE), asymptomatic Zika Virus infections in pregnant women who do not have known pregnancy Complications are not reportable. ArboNET does not currently include pregnancy Surveillance information (e.g., gestational age or pregnancy exposures) or pregnancy outcomes. To understand the full impact of infection on the fetus and neonate, other systems are needed for reporting and active monitoring of pregnant women with laboratory evidence of possible Zika Virus infection during pregnancy. Thus, in collaboration with state, local, tribal, and territorial health departments, CDC established two Surveillance systems to monitor pregnancies and Congenital outcomes among women with laboratory evidence of Zika Virus infection† in the United States and territories: 1) the U.S. Zika Pregnancy Registry (USZPR),§ which monitors pregnant women residing in U.S. states and all U.S. territories except Puerto Rico, and 2) the Zika Active Pregnancy Surveillance System (ZAPSS), which monitors pregnant women residing in Puerto Rico. As of May 12, 2016, the Surveillance systems were monitoring 157 and 122 pregnant women with laboratory evidence of possible Zika Virus infection from participating U.S. states and territories, respectively. Tracking and monitoring clinical presentation of Zika Virus infection, all prenatal tTesting, and adverse consequences of Zika Virus infection during pregnancy are critical to better characterize the risk for Congenital infection, the performance of prenatal diagnostic tTesting, and the spectrum of adverse Congenital outcomes. These data will improve clinical guidance, inform counseling messages for pregnant women, and facilitate planning for clinical and public health services for affected families.

What is already known about this topic? Zika Virus infection during pregnancy causes microcephaly and other serious brain abnormalities. However, the full range of outcomes of asymptomatic and symptomatic Zika Virus infection during pregnancy are not yet well understood.

What is added by this report? In February 2016, CDC, in collaboration with state, local, tribal, and territorial health departments, launched comprehensive Surveillance systems to report and actively monitor pregnancies and Congenital outcomes among symptomatic and asymptomatic women with laboratory evidence of possible Zika Virus infection. As of May 12, 2016, there were 157 and 122 pregnant women with laboratory evidence of possible Zika Virus infection residing in U.S. states and U.S. territories, respectively.

What are the implications for public health practice? This report launches the Weekly Reporting of pregnant women with laboratory evidence of possible Zika Virus infection in U.S. states and territories. Monitoring all pregnant women with possible Zika Virus infection during pregnancy, whether asymptomatic or symptomatic, will enhance understanding of possible adverse outcomes and allow better estimates of the number of pregnancies at risk for adverse outcomes. This information will assist health care providers who counsel pregnant women and will facilitate planning services for affected families.

Suggested citation for this article: Simeone RM, Shapiro-Mendoza CK, Meaney-Delman D, et al. Possible Zika Virus Infection Among Pregnant Women — United States and Territories, May 2016. MMWR Morb Mortal Wkly Rep. ePub: 20 May 2016. DOI: http://dx.doi.org/10.15585/mmwr.mm6520e1.



PMID: MODS





http://dx.doi.org/10.15585/mmwr.mm6520e1


Subjects:
[+]
Pregnant Women Zika Virus Infection Zika Virus Infection/Transmission
Series:
MMWR. Morbidity and Mortality Weekly Report ; v. 65, no. 20, p. 514-519
Document Type:
Journal Article
Place as Subject:
United States
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:117195dd731ad7d9135da3f146e50d08ebdde5c4a031daed3ee6789049b36fe0
Download URL:
https://stacks.cdc.gov/view/cdc/39550/cdc_39550_DS1.pdf
File Type:

Supporting Files

• No Additional Files

More +